JUN 29, 2016 07:30 AM PDT

Charge Heterogeneity Analysis of Biologics by Capillary Isoelectric Focusing (cIEF) and Capillary Zone Electrophoresis (CZE)

SPONSORED BY: Sciex, Sciex
C.E. CREDITS: P.A.C.E. CE
Speakers
  • Manager, CE Field Applications Support, SCIEX Separations
    Biography

           Brandon Bates is currently the Field Applications Support Manager with Sciex Separations. He began his CE customer support career with Beckman Coulter in 2010, transitioning to Sciex in 2014. During this six year period, Brandon had overseen the installation and successful implementation of every Sciex CE instrument in the Central US through onsite support and training. He also oversees all CE applications specialists in the US.
           Prior to his time with Sciex Separations, he gained experience while employed at the University of Iowa department of Internal Medicine, followed by a position with the Department of Microbial Systems Biology at Argonne National Laboratory.


    Abstract:
         Implementation of Capillary Electrophoresis (CE) technology in the biopharmaceutical industry is helping to characterize purity, heterogeneity, and identity of therapeutic proteins. Furthermore, the charge heterogeneity profile of protein samples can be revealed through CE, with excellent resolution. Determine protein isoform charge heterogeneity with high speed, high resolution capillary isoelectric focusing (cIEF) and zone electrophoresis (CZE).
         cIEF is a powerful technique that allows for ultra-high resolution and quantitative analysis of proteins separated based on isoelectric point (pI). Alternatively, you can obtain high resolution charge heterogeneity information more rapidly with reduced sample preparation, using Capillary Zone Electrophoresis.
         Using fully optimized methods and synthetic pI markers in cIEF attains the highest levels of precision in pI determination and direct isoform quantitation. The PA 800 Plus Pharmaceutical Analysis System enhances these applications by providing excellent intermediate precision with pI reproducibility < 1% (cIEF), peak migration time reproducibility < 3% (CZE) and peak area reproducibility < 3% (cIEF/CZE). Join us to discover the advantages of cIEF & CZE methods for charge heterogeneity applications.

    Learning Objectives:
    • Basic fundamentals of charge heterogeneity CE techniques 
    • Introduction to our two distinct charge heterogeneity applications: cIEF and CZE
    • Advantages of each charge heterogeneity technique

    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    MAY 29, 2018 09:00 AM PDT
    C.E. CREDITS
    MAY 29, 2018 09:00 AM PDT
    Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells withi...
    Loading Comments...